SOPHROSYNE CAPITAL LLC - Q3 2014 holdings

$84.7 Million is the total value of SOPHROSYNE CAPITAL LLC's 58 reported holdings in Q3 2014. The portfolio turnover from Q2 2014 to Q3 2014 was 53.8% .

 Value Shares↓ Weighting
ZLTQ SellZELTIQ AESTHETICS INC$8,697,000
+33.5%
384,418
-10.3%
10.26%
+54.7%
BEAT SellBIOTELEMETRY INC$7,559,000
-8.8%
1,126,974
-2.5%
8.92%
+5.7%
MSTR SellMICROSTRATEGY INCcl a new$5,856,000
-18.3%
44,750
-12.3%
6.91%
-5.4%
HIIQ SellHEALTH INS INNOVATIONS INC$5,609,000
-18.5%
519,870
-7.0%
6.62%
-5.6%
BDSI SellBIODELIVERY SCIENCES INTL IN$3,284,000
-31.1%
192,176
-51.4%
3.88%
-20.2%
ADHD SellALCOBRA LTD$2,468,000
-53.0%
159,826
-47.4%
2.91%
-45.6%
PKT SellPROCERA NETWORKS INC$2,310,000
-18.9%
240,906
-14.6%
2.73%
-6.0%
PTIE SellPAIN THERAPEUTICS INC$2,273,000
-58.5%
581,762
-38.8%
2.68%
-51.9%
CSII SellCARDIOVASCULAR SYS INC DEL$2,170,000
-25.1%
91,841
-1.2%
2.56%
-13.2%
DRRX SellDURECT CORP$1,766,000
-23.5%
1,202,112
-5.3%
2.08%
-11.4%
UBNT SellUBIQUITI NETWORKS INC$1,188,000
-49.3%
31,713
-38.9%
1.40%
-41.3%
SANW SellS&W SEED CO$1,118,000
-55.6%
263,941
-31.9%
1.32%
-48.5%
P SellPANDORA MEDIA INC$1,021,000
-30.5%
42,300
-15.2%
1.20%
-19.5%
SYRG SellSYNERGY RES CORP$119,000
-23.7%
9,800
-16.9%
0.14%
-11.9%
LMNR SellLIMONEIRA CO$104,000
-14.0%
4,400
-20.0%
0.12%0.0%
KTOS SellKRATOS DEFENSE & SEC SOLUTIO$98,000
-51.5%
15,000
-42.1%
0.12%
-43.7%
CVGW SellCALAVO GROWERS INC$72,000
-42.4%
1,600
-56.8%
0.08%
-33.1%
GLOG SellGASLOG LTD$44,000
-69.4%
2,000
-55.6%
0.05%
-64.6%
RNET ExitRIGNET INC$0-1,000
-100.0%
-0.06%
PDCE ExitPDC ENERGY INC$0-1,000
-100.0%
-0.06%
AGRO ExitADECOAGRO S A$0-11,300
-100.0%
-0.11%
PNR ExitPENTAIR PLC$0-1,500
-100.0%
-0.11%
AWK ExitAMERICAN WTR WKS CO INC NEW$0-2,400
-100.0%
-0.12%
SPHS ExitSOPHIRIS BIO INC$0-93,900
-100.0%
-0.22%
IG ExitIGI LABS INC$0-62,500
-100.0%
-0.34%
EVOK ExitEVOKE PHARMA INC$0-49,000
-100.0%
-0.40%
ININ ExitINTERACTIVE INTELLIGENCE GRO$0-8,100
-100.0%
-0.46%
UPI ExitUROPLASTY INC$0-172,600
-100.0%
-0.47%
ETRM ExitENTEROMEDICS INC$0-300,000
-100.0%
-0.48%
ARWR ExitARROWHEAD RESH CORP$0-35,458
-100.0%
-0.52%
EXAS ExitEXACT SCIENCES CORP$0-31,700
-100.0%
-0.55%
AVGTF ExitAVG TECHNOLOGIES N V$0-30,400
-100.0%
-0.62%
REPH ExitRECRO PHARMA INC$0-101,000
-100.0%
-0.82%
WATT ExitENERGOUS CORP$0-61,800
-100.0%
-0.95%
TROX ExitTRONOX LTD$0-35,100
-100.0%
-0.96%
NESCQ ExitNUVERRA ENVIRONMENTAL SOLUTI$0-52,300
-100.0%
-1.07%
ARAY ExitACCURAY INC$0-141,500
-100.0%
-1.27%
CPRX ExitCATALYST PHARM PARTNERS INC$0-600,000
-100.0%
-1.55%
PCLN ExitPRICELINE GRP INC$0-1,400
-100.0%
-1.72%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2014-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
PURECYCLE CORP10Q3 201525.2%
MEETME INC9Q2 20158.3%
CADIZ INC9Q3 20156.6%
ENVIVIO INC9Q2 20153.3%
LIMONEIRA CO9Q3 20150.6%
ZELTIQ AESTHETICS INC8Q1 201510.3%
MICROSTRATEGY INC8Q1 20158.5%
BIODELIVERY SCIENCES INTL IN8Q1 20155.3%
PROCERA NETWORKS INC8Q1 20153.7%
AXOGEN INC8Q2 20155.6%

View SOPHROSYNE CAPITAL LLC's complete holdings history.

Latest significant ownerships (13-D/G)
SOPHROSYNE CAPITAL LLC Q3 2014 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
ASPEN GROUP, INC.February 12, 20161,690,4901.3%
MeetMe, Inc.April 07, 20141,855,8354.8%
Venaxis, Inc.Sold outJanuary 29, 201400.0%
VENTRUS BIOSCIENCES INCSold outJanuary 29, 201400.0%
S&W Seed CoOctober 01, 2013554,2134.8%
CardioNet, Inc.September 23, 20131,038,5184.1%
SMITH MICRO SOFTWARE INCAugust 22, 20131,827,9984.9%
Coastal Contacts IncJune 14, 20131,100,2633.4%
BIODELIVERY SCIENCES INTERNATIONAL INCApril 05, 20131,595,4414.2%
Stereotaxis, Inc.Sold outApril 05, 201300.0%

View SOPHROSYNE CAPITAL LLC's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2016-02-12
13F-HR2015-11-13
13F-HR2015-08-14
13F-HR2015-04-20
13F-HR2015-01-26
SC 13G/A2015-01-26
13F-HR2014-11-14
SC 13G/A2014-09-10
13F-HR2014-08-14
13F-HR2014-05-14

View SOPHROSYNE CAPITAL LLC's complete filings history.

Compare quarters

Export SOPHROSYNE CAPITAL LLC's holdings